AI English summary of an SEC filing — figures as filed

DuPont agreed with Chemours, Corteva and others to a Judicial Consent Order to resolve outstanding claims by the State of New Jersey related to legacy substances, and will make aggregate cash payments to the State of New Jersey of $875 million over 25 years.

8-KEntry into a Material Definitive AgreementFiled Aug 4, 2025Period of report Aug 3, 2025Summary published (UTC) Oct 13, 2026

Key points

AI summary

DuPont agreed with Chemours, Corteva and others to a Judicial Consent Order to resolve outstanding claims by the State of New Jersey related to legacy substances, and will make aggregate cash payments to the State of New Jersey of $875 million over 25 years.
The company estimated its share of the cash payment under the MOU at $311 million and recorded a pre-tax charge of $177 million within discontinued operations in Q2 2025, reflecting the net present value using a 8% discount rate. The first payment will be due within 30 days of the date the Judicial Consent Order is entered by the Court, but no earlier than January 31, 2026.
The company said it will continue to undertake remediation at the four sites in accordance with the Settlement, and DuPont and Corteva will establish a Reserve Fund in the amount of $475 million to be funded in the form of surety bond or similar financial instrument. DuPont is responsible for the remedial funding source at the Parlin site, and the company explained that changes to its environmental reserve estimates could result from a binding third-party review process.
Contingent upon Court approval, DuPont and Corteva will purchase Chemours' interest in future PFAS-related insurance proceeds by contributing a total of $150 million ($106.5 million from DuPont) into an escrow fund. The Settlement is subject to a public notice and comment period and Court approval, and the company said it does not admit any liability or wrongdoing.

Summary

AI-written

Analysis scope · Filing body only (exhibits excluded)We analyzed the filing body only. The exhibits exceeded the length limit and were excluded, so figures, financial statements and presentation materials in them were not reviewed.

Judicial Consent Order with New Jersey and aggregate cash payments

DuPont agreed with Chemours, Corteva and others to a Judicial Consent Order to resolve outstanding claims by the State of New Jersey related to legacy substances, and will make aggregate cash payments to the State of New Jersey of $875 million over 25 years.

Source · Based on the filing body (exhibits excluded)

DuPont's share of $311 million and pre-tax charge of $177 million

The company estimated its share of the cash payment under the MOU at $311 million and recorded a pre-tax charge of $177 million within discontinued operations in Q2 2025, reflecting the net present value using a 8% discount rate. The first payment will be due within 30 days of the date the Judicial Consent Order is entered by the Court, but no earlier than January 31, 2026.

Source · Based on the filing body (exhibits excluded)

Remediation obligations and Reserve Fund of $475 million

The company said it will continue to undertake remediation at the four sites in accordance with the Settlement, and DuPont and Corteva will establish a Reserve Fund in the amount of $475 million to be funded in the form of surety bond or similar financial instrument. DuPont is responsible for the remedial funding source at the Parlin site, and the company explained that changes to its environmental reserve estimates could result from a binding third-party review process.

Source · Based on the filing body (exhibits excluded)

Purchase of Chemours' insurance proceeds and Court approval condition

Contingent upon Court approval, DuPont and Corteva will purchase Chemours' interest in future PFAS-related insurance proceeds by contributing a total of $150 million ($106.5 million from DuPont) into an escrow fund. The Settlement is subject to a public notice and comment period and Court approval, and the company said it does not admit any liability or wrongdoing.

Source · Based on the filing body (exhibits excluded)

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.